Article
Molecular Targets in Alzheimer’s Disease: From Pathogenesis to Therapeutics
1 Jan 2015
Abstract excerpt
Alzheimer's disease (AD) is characterized by progressive cognitive decline usually beginning with impairment in the ability to form recent memories. Nonavailability of definitive therapeutic strategy urges developing pharmacological targets based on cell signaling pathways. A great revival of interest in nutraceuticals and adjuvant therapy has been put forward. Tea polyphenols for their multiple health benefits...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
